| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | American Health Packaging | 2026-09-15 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Gilead Sciences, Inc. | 2026-09-09 |
| These highlights do not include all the information needed to use EMTRICITABINE CAPSULES safely and effectively. See full prescribing information for EMTRICITABINE CAPSULES. EMTRICITABINE capsules, for oral use Initial U.S. Approval: 2003 | Product name | Cipla USA Inc. | CIPLA LIMITED GOA | CIPLA LIMITED KURKUMBH | 2026-08-18 |
| These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Merck Sharp & Dohme LLC | 2026-07-08 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Gilead Sciences, Inc. | 2026-07-07 |
| These highlights do not include all the information needed to use DESCOVY safely and effectively. See full prescribing information for DESCOVY. DESCOVY ® (emtricitabine and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | Product name | Gilead Sciences, Inc. | 2026-07-07 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Major Pharmaceuticals | 2026-05-21 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | NuCare Pharmaceuticals, Inc. | 2026-04-20 |
| These highlights do not include all the information needed to use SYMTUZA safely and effectively. See full prescribing information for SYMTUZA. SYMTUZA ® (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Janssen Products LP | AMPAC Fine Chemicals | Gilead Alberta ULC | Patheon, Inc. | Evonik Operations GmbH | Janssen Pharmaceutica NV | Union Quimico Farmaceutica SA (Uquifa) | Janssen Cilag SpA | Esteve Quimica, SA | Yuhan Chemical, Inc. | Janssen Ortho LLC | Janssen Pharmaceuticals, Inc. | Janssen Pharmaceutical Sciences Unlimited Company | Porton Pharma Solutions Ltd | Thermo Fisher Scientific Cork Limited | 2026-04-17 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Gilead Sciences, Inc. | 2026-03-30 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | Bryant Ranch Prepack | 2026-03-11 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Bryant Ranch Prepack | 2026-03-10 |
| These highlights do not include all the information needed to use EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE, RILPIVIRINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2011 | Product name | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 2026-03-05 |
| These highlights do not include all the information needed to use VIREAD safely and effectively. See full prescribing information for VIREAD. GILEAD ACCESS PROGRAM VIREAD™ (tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2001 | Product name | Gilead Sciences, Inc. | 2026-02-13 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Gilead Sciences, Inc. | 2026-02-12 |
| These highlights do not include all the information needed to use TYBOST safely and effectively. See full prescribing information for TYBOST. TYBOST ® (cobicistat) tablets, for oral use Initial U.S. Approval: 2012 | Product name | Gilead Sciences, Inc. | 2026-02-10 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Proficient Rx LP | 2026-02-01 |
| These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 2015 | Product name | Janssen Products, LP | Gilead Alberta ULC | Cilag AG | Porton Pharma Solutions Ltd | Janssen Ortho LLC | Janssen Pharmaceutical Sciences Unlimited Company | Thermo Fisher Scientific Cork Limited | Yuhan Chemical, Inc. | Patheon Inc. | 2026-02-01 |
| These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 2015 | Product name | Janssen Products, LP | Gilead Alberta ULC | Cilag AG | Porton Pharma Solutions Ltd | Janssen Ortho LLC | Janssen Pharmaceutical Sciences Unlimited Company | Thermo Fisher Scientific Cork Limited | Yuhan Chemical, Inc. | Patheon Inc. | 2026-02-01 |
| TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Rx only These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | AvKARE | 2026-01-15 |
| Tenofovir Disoproxil Fumarate Tablets Rx only These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. Initial U.S. Approval Date: 2001 | Product name | AvPAK | 2026-01-09 |
| These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Strides Pharma Science Limited | Strides Pharma Global Pte. Ltd. | 2026-01-08 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Major Pharmaceuticals | 2025-12-24 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Redpharm Drug | 2025-12-13 |
| These highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA ® (emtricitabine) capsule, for oral use EMTRIVA ® (emtricitabine) oral solution Initial U.S. Approval: 2003 | Product name | Gilead Sciences, Inc. | 2025-12-02 |
| These highlights do not include all the information needed to use ODEFSEY safely and effectively. See full prescribing information for ODEFSEY. ODEFSEY ® (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2016 | Product name | Gilead Sciences, Inc. | 2025-12-02 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablet, for oral use Initial U.S. Approval: 2006 | Product name | NuCare Pharmaceuticals, Inc. | 2025-11-05 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Product name | Bryant Ranch Prepack | 2025-11-04 |
| These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Merck Sharp & Dohme LLC | 2025-10-29 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2025-10-23 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | A-S Medication Solutions | 2025-10-17 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | PD-Rx Pharmaceuticals, Inc. | 2025-10-09 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Bryant Ranch Prepack | 2025-09-29 |
| These highlights do not include all the information needed to use PREZISTA safely and effectively. See Full Prescribing Information for PREZISTA. PREZISTA ® (darunavir) oral suspension PREZISTA ® (darunavir) tablet, for oral use Initial U.S. Approval: 2006 | Product name | Janssen Products LP | Janssen Pharmaceuticals, Inc | Janssen Pharmaceutica NV | Cilag AG | Porton Pharma Solutions Ltd | Janssen Cilag SpA | JANSSEN ORTHO LLC | Janssen Pharmaceutical Sciences Unlimited Company | Thermo Fisher Scientific Cork Limited | 2025-08-29 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 2025-08-20 |
| These highlights do not include all the information needed to use EMTRICITABINE CAPSULES safely and effectively. See full prescribing information for EMTRICITABINE CAPSULES. EMTRICITABINE capsules, for oral use Initial U.S. Approval: 2003 | Product name | Cipla USA Inc. | CIPLA LIMITED GOA | CIPLA LIMITED KURKUMBH | 2025-08-05 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval Date: 2001 | Product name | Strides Pharma Science Limited | 2025-08-02 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Product name | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 2025-07-28 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Major Pharmaceuticals | 2025-07-18 |
| These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA ® (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2011 | Product name | Gilead Sciences, Inc. | 2025-07-16 |
| These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS PROGRAM Initial U.S. Approval: 2011 | Product name | Gilead Sciences, Inc. | 2025-07-16 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | Product name | Gilead Sciences, Inc | 2025-07-16 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA™ (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS PROGRAM Initial U.S. Approval: 2004 | Product name | Gilead Sciences, Inc | 2025-07-16 |
| These highlights do not include all the information needed to use VEMLIDY safely and effectively. See full prescribing information for VEMLIDY. VEMLIDY ® (tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | Product name | Gilead Sciences, Inc. | 2025-07-14 |
| EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. Initial U.S. Approval: 2004 | Product name | AvKARE | 2025-07-01 |
| These highlights do not include all the information needed to use DESCOVY safely and effectively. See full prescribing information for DESCOVY. DESCOVY ® (emtricitabine and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | Product name | Gilead Sciences, Inc. | 2025-06-20 |
| These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Merck Sharp & Dohme LLC | 2025-06-12 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | Bryant Ranch Prepack | 2025-06-05 |
| These highlights do not include all the information needed to use EVOTAZ safely and effectively. See full prescribing information for EVOTAZ. EVOTAZ ® (atazanavir and cobicistat) tablet, for oral use Initial U.S. Approval: 2015 | Product name | E.R. Squibb & Sons, L.L.C. | 2025-05-12 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | NuCare Pharmaceuticals, Inc. | 2025-04-18 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | 2025-04-14 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | Camber Pharmaceuticals, Inc. | Annora Pharma Private Limited | 2025-03-19 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Macleods Pharmaceuticals Limited | 2025-03-03 |
| These highlights do not include all the information needed to use VIREAD safely and effectively. See full prescribing information for VIREAD. VIREAD ® (tenofovir disoproxil fumarate) tablets, for oral use VIREAD ® (tenofovir disoproxil fumarate) powder, for oral use Initial U.S. Approval: 2001 | Product name | Gilead Sciences, Inc. | 2025-02-18 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Florida Pharmaceutical Products, LLC. | Shandong Anhong Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) | 2025-02-11 |
| These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2012 | Product name | Gilead Sciences, Inc. | 2025-02-04 |
| These highlights do not include all the information needed to use GENVOYA safely and effectively. See full prescribing information for GENVOYA. GENVOYA ® (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | Product name | Gilead Sciences, Inc. | 2025-02-03 |
| Emtricitabine/TDF | Product name | Direct_Rx | 2025-01-22 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Product name | DirectRx | 2025-01-21 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Quinn Pharmaceuticals | Shandong Anhong Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) | 2025-01-10 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | NuCare Pharmaceuticals, Inc. | 2024-12-26 |
| These highlights do not include all the information needed to use EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE, RILPIVIRINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2011 | Product name | Mylan Pharmaceuticals Inc. | 2024-12-14 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval Date: 2001 | Product name | Strides Pharma Science Limited | 2024-12-12 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Cipla USA Inc. | CIPLA LIMITED KURKUMBH | APPCO PHARMA LLC | 2024-12-05 |
| Emtricitabine and Tenofovir Disoproxil Fumarate Tablets | Product name | Zydus Lifesciences Limited | 2024-11-28 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | PD-Rx Pharmaceuticals, Inc. | 2024-10-09 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR Disoproxil Fumarate Tablets, for oral use Initial U.S. Approval: 2004 | Product name | Proficient Rx LP | 2024-10-01 |
| These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Teva Pharmaceuticals USA, Inc. | 2024-09-30 |
| EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets | Product name | RedPharm Drug, Inc. | RedPharm Drug | 2024-08-07 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR disoproxil fumarate tablets, for oral use Initial U.S. Approval: 2004 | Product name | Redpharm Drug, Inc. | LUPIN LIMITED | 2024-08-07 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR Disoproxil Fumarate Tablets, for oral use Initial U.S. Approval: 2004 | Product name | Redpharm Drug, Inc. | 2024-08-07 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | A-S Medication Solutions | 2024-08-05 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Redpharm Drug | 2024-07-24 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Redpharm Drug, Inc. | Zydus Pharmaceuticals USA Inc. | 2024-07-18 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | Product name | NuCare Pharmaceuticals,Inc. | 2024-07-16 |
| RedPharm Drug, Inc. human prescription drug label | Product name | RedPharm Drug, Inc. | 2024-07-15 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablet, for oral use Initial U.S. Approval: 2006 | Product name | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 2024-06-22 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS . EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Mylan Pharmaceuticals Inc. | 2024-06-10 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | American Health Packaging | 2024-06-09 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | QUALLENT PHARMACEUTICALS HEALTH LLC | Aurobindo Pharma Limited | 2024-06-09 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Aurobindo Pharma Limited | 2024-06-09 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Aurobindo Pharma Limited | 2024-06-07 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Product name | Teva Pharmaceuticals USA, Inc. | 2024-05-28 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | A-S Medication Solutions | 2024-05-16 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2024-05-10 |
| These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018 | Product name | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 2024-05-07 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | A-S Medication Solutions | 2024-04-30 |
| Darunavir Tablets | Product name | Zydus Lifesciences Limited | 2024-04-29 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | Viona Pharmaceuticals Inc | Zydus Lifesciences Limited | 2024-04-29 |
| EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg, for oral use Initial U.S. Approval: 2004 | Product name | Golden State Medical Supply, Inc. | 2024-04-08 |
| These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg, for oral use Initial U.S. Approval: 2004 | Product name | Strides Pharma Inc. | 2024-03-18 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Cipla USA Inc. | CIPLA LIMITED GOA | CIPLA LIMITED KURKUMBH | 2024-03-06 |
| These highlights do not include all the information needed to use EMTRICITABINE CAPSULES safely and effectively. See full prescribing information for EMTRICITABINE CAPSULES. EMTRICITABINE capsule, for oral use Initial U.S. Approval: 2003 | Product name | Aurobindo Pharma Limited | 2024-02-07 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | EXELAN PHARMACEUTICALS INC. | Cipla USA Inc. | CIPLA LIMITED KURKUMBH | InvaGen Pharmaceuticals, Inc | 2024-01-19 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | Cipla USA Inc. | CIPLA LIMITED KURKUMBH | CIPLA LIMITED PATALGANGA | InvaGen Pharmaceuticals, Inc | 2024-01-18 |
| Tenofovir Disoproxil Fumarate Tablets Rx only These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. Initial U.S. Approval Date: 2001 | Product name | AvPAK | 2024-01-08 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2024-01-03 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Aurobindo Pharma Limited | 2024-01-03 |
| These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use Initial U.S. Approval: 2015 | Product name | A-S Medication Solutions | 2024-01-02 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Product name | Aurobindo Pharma Limited | 2023-12-28 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED | 2023-11-29 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See full prescribing information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | Dr.Reddys Laboratories Inc | Laurus Laboratories Limited | 2023-11-25 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See full prescribing information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited | 2023-11-21 |
| These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018 | Product name | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 2023-11-15 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR disoproxil fumarate tablets, for oral use Initial U.S. Approval: 2004 | Product name | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2023-11-02 |
| These highlights do not include all the information needed to use DARUNAVIR TABLETS safely and effectively. See Full Prescribing Information for DARUNAVIR TABLETS. DARUNAVIR tablets, for oral use Initial U.S. Approval: 2006 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | 2023-10-05 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Bryant Ranch Prepack | 2023-08-11 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | RPK Pharmaceuticals, Inc. | 2023-08-10 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Macleods Pharmaceuticals Limited | 2023-05-25 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | 2023-01-26 |
| TENOFOVIR DISOPROXIL FUMARATE TABLETS These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Chartwell RX, LLC. | Chartwell Pharmaceuticals Congers, LLC | 2022-12-12 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Qilu Pharmaceutical Co., Ltd. | Shandong Anhong Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) | 2022-10-27 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Product name | Camber Pharmaceuticals, Inc. | Annora Pharma Private Limited | 2022-07-28 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | NorthStar RxLLC | Macleods Pharmaceuticals Limited | 2022-07-25 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR disoproxil fumarate tablets, for oral use Initial U.S. Approval: 2004 | Product name | A-S Medication Solutions | 2022-04-28 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Product name | Macleods Pharmaceuticals Limited | 2021-09-18 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Amneal Pharmaceuticals NY LLC | 2021-08-28 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | Product name | A-S Medication Solutions | 2021-06-15 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Product name | DIRECT RX | 2021-06-01 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Exelan Pharmaceuticals, Inc. | appco-pharma-llc | 2021-04-06 |